SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Izzy who wrote (2282)10/10/1997 9:46:00 PM
From: Oliver & Co   of 6136
 
No, I did not read it, I did not get it. But I spoke to the rep, who had called me re. the Advisors meeting, and he told me that there was an MMP inhibitor, which was "A Cancer Killer", they had tried it in several types of tumors, and it worked great. Apparently this compound cuts blood flow to the tumor.

So I would vote ???? maybe, yes. Let me ask Dr. Crosson first. After all they got 1% (~3 million shares), do you think it was at $56 or at $42?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News